Isotechnika Pharma Inc IPHAF

JANUARY 28, 2012----SECOND DEVELOPMENT PAYMENT

[ISAloser247]

---NO NEWS,  NOTHING!!!!!  According to the Iljin Life Science Co. Agreement, on or before the above date, IF the Joint Steering Commitee has determined 'satisfactorily advanced Phase 3 clinical trial' planning,  Iljin shall pay U.S.$500,000 and shall purchase 39.6 million shares , issued from the Company treasury, for an aggregate subscription price of U.S. $8.5 million.

ANY e-mails from Liz, at the ISA bunker?   Are the corks a-poppin as LONG-TIME SUFFERING SHAREHOLDERS get screwed and DILUTED again?     Any cars in the parking lot?